Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $11.35, for a total value of $340,500.00. Following the completion of the sale, the insider now directly owns 1,696,097 shares in the company, valued at approximately $19,250,700.95. The trade was a 1.74 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, October 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.77, for a total value of $323,100.00.
• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The shares were sold at an average price of $9.02, for a total value of $63,807.48.

Alignment Healthcare Trading Down 10.5 %

Shares of ALHC stock traded down $1.35 on Friday, reaching $11.49. 15,157,138 shares of the stock were exchanged, compared to its average volume of 1,107,887. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $14.25. The stock has a market cap of $2.20 billion, a P/E ratio of -14.92 and a beta of 1.45. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a 50 day moving average of $11.55 and a two-hundred day moving average of $9.31.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The firm had revenue of $692.43 million during the quarter, compared to the consensus estimate of $662.11 million. During the same period in the prior year, the firm earned ($0.19) EPS. The firm’s quarterly revenue was up 51.6% compared to the same quarter last year. On average, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ALHC. UBS Group boosted their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. KeyCorp began coverage on Alignment Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Robert W. Baird boosted their price target on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a report on Wednesday, August 14th. Barclays boosted their price target on Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 30th. Finally, TD Cowen boosted their price target on Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $10.33.

Institutional Trading of Alignment Healthcare

Several large investors have recently added to or reduced their stakes in the stock. Barclays PLC increased its holdings in Alignment Healthcare by 144.1% in the 3rd quarter. Barclays PLC now owns 193,446 shares of the company’s stock valued at $2,287,000 after purchasing an additional 114,191 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Alignment Healthcare in the 3rd quarter valued at about $523,000. State Street Corp boosted its position in Alignment Healthcare by 0.9% in the 3rd quarter. State Street Corp now owns 2,252,287 shares of the company’s stock valued at $26,622,000 after buying an additional 20,731 shares during the last quarter. Atom Investors LP purchased a new position in Alignment Healthcare in the 3rd quarter valued at about $961,000. Finally, PDT Partners LLC boosted its position in Alignment Healthcare by 14.3% in the 3rd quarter. PDT Partners LLC now owns 125,532 shares of the company’s stock valued at $1,484,000 after buying an additional 15,726 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.